This analysis assessed changes in serum 25-hydroxyvitamin D ( 25 [ OH ] D ; the precursor form of active vitamin D ) in antiretroviral-naive adults receiving rilpivirine or efavirenz over 48 weeks in a randomized , double-blind , Phase III trial ( ECHO ) .